| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 11/03/2009 | US7612063 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 4-oxo-4H-pyrido[3,2,1-kl]benzo[g]-phenoxazine for example; Tumor suppression agents with reduced side effects; anticancer |
| 11/03/2009 | US7612062 Pyrrolobenzodiazepines |
| 10/29/2009 | WO2009131973A1 Quinolone derivatives useful as antibacterial agents |
| 10/29/2009 | WO2009130231A1 Pyrrolo [1, 2-a] pyrazine derivatives as vasopressin vib receptor antagonists |
| 10/29/2009 | US20090270446 Diamine derivatives |
| 10/29/2009 | US20090270388 Fused azole-pyrimidine derivatives |
| 10/28/2009 | EP1751166B1 Mono-, oligo- and polythieno[3,2-b]thiophenes |
| 10/28/2009 | CN100554268C Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 10/27/2009 | CA2437006C Aminotriazolopyridine derivatives as adenosine receptor ligands |
| 10/27/2009 | CA2341434C Pyrrolobenzodiazepine compounds |
| 10/22/2009 | WO2009128019A1 Tricyclic antibiotics |
| 10/22/2009 | CA2720672A1 Tricyclic antibiotics |
| 10/21/2009 | EP1450811B1 Compounds specific to adenosine A1 and A3 receptors and uses thereof |
| 10/21/2009 | CN101563323A Spiro-piperidine derivatives |
| 10/21/2009 | CN101560213A Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application |
| 10/20/2009 | US7605262 Podophyllotoxin derivatives |
| 10/20/2009 | CA2520898C Non-cross-linking pyrrolo(2,1-c)(1,4)benzodiazepines as potential antitumour agents and process thereof |
| 10/20/2009 | CA2380852C Tricyclic compounds having spiro union |
| 10/20/2009 | CA2214793C Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds |
| 10/15/2009 | WO2009125809A1 Piperidine derivatives |
| 10/15/2009 | WO2009125808A1 Aminocyclohexyl derivative |
| 10/15/2009 | US20090258856 Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 10/15/2009 | CA2721099A1 Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene a4 hydrolase |
| 10/14/2009 | EP1636235B1 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors |
| 10/14/2009 | EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 10/14/2009 | CN101558070A Triazolo-pyridazine protein kinase modulators |
| 10/14/2009 | CN101555253A Ruthenium polypyridyl complex inducing DNA to condense, preparation method and application thereof |
| 10/08/2009 | US20090253685 Product comprising at least one Cdc25 phosphatase inhibitor in combination with at least one other anti-cancer agent |
| 10/07/2009 | EP2106396A2 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors |
| 10/07/2009 | CN101550154A Cephalosporin derivative with pyrazolo triazole |
| 10/06/2009 | US7598268 Vascular endothelial growth factor; tyrosine kinase inhibitor;angiogenesis inhibitor; anticarcinogenic agents |
| 10/06/2009 | US7598247 Immunomodulating heterocyclic compounds |
| 10/06/2009 | US7597955 Light-emitting device, organic compound and display |
| 10/06/2009 | CA2368095C Process for preparing inhibitors of nucleoside metabolism |
| 10/06/2009 | CA2180479C Method for treatment of obesity using prolactin modulators and diet |
| 10/01/2009 | WO2009065922A3 Organic compounds |
| 10/01/2009 | US20090242837 Charge transport compositions and electronic devices made with such compositions |
| 09/30/2009 | CN100545160C Diamine derivatives |
| 09/24/2009 | CA2755235A1 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 09/23/2009 | EP2103620A1 Fused heterocyclic compound |
| 09/23/2009 | EP2103619A1 Imidazothiazole derivatives |
| 09/23/2009 | EP2102212A1 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 09/23/2009 | EP2102207A1 Spiro-piperidine derivatives as via receptor antagonists |
| 09/23/2009 | EP2102170A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/23/2009 | EP2101741A2 Solid dispersion comprising a poorly water soluble drug |
| 09/23/2009 | EP1699797B1 Pyrrolotriazine compounds as kinase inhibitors |
| 09/22/2009 | US7593652 Image forming apparatus and image forming system that calculate operation amount of components thereof |
| 09/22/2009 | US7592354 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength |
| 09/22/2009 | US7592143 Induction of capacse cascade ; administering apoptosis inducing protein; drug screening; anticancer agents |
| 09/17/2009 | WO2009113084A1 C2-fluoro substituted piperazine linked pyrrolo[2,1-c][1,4] benzodiazepine dimers and a process for the preparation thereof |
| 09/16/2009 | EP2099800A1 7-substituted purine derivatives for immunosuppression |
| 09/16/2009 | EP1414825B9 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/16/2009 | CN100540554C New compound capable of being used in organic layer of organic light emitting device |
| 09/15/2009 | US7589201 Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 09/15/2009 | US7589102 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 09/15/2009 | US7589097 Using compounds such as 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine for therapy of Parkinson's disease; adenosine receptor antagonist; antidepressant, neurodegenerative disorders, cognition activator, attention deficit disorder |
| 09/10/2009 | US20090227567 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 09/09/2009 | EP2096923A2 Heteroaryl amide derivatives |
| 09/09/2009 | EP1474150B1 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of cardiac insufficiency |
| 09/09/2009 | CN100537570C Dihydropteridinones, method for the production and use thereof in the form of drugs |
| 09/08/2009 | US7585876 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 09/08/2009 | US7585873 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 09/08/2009 | CA2463598C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists |
| 09/08/2009 | CA2286560C Vinca alkaloid antimitotic halogenated derivatives |
| 09/03/2009 | WO2009106445A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | WO2009106442A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | WO2009106441A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | WO2009062676A3 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 09/03/2009 | US20090221821 Adenosine receptor antagonists and methods of making and using the same |
| 09/03/2009 | US20090221699 Fab I Inhibitors |
| 09/03/2009 | CA2716223A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | CA2714111A1 Tetrahydro-1h-pyrrolo fused pyridones |
| 09/03/2009 | CA2713710A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | CA2713324A1 Pyrrolopyrazine kinase inhibitors |
| 09/01/2009 | US7582631 Paget's disease; muscular disorders; cardiovascular disorders; antiinflamamtory agents; antidiabetic agents; autoimmune disease; leukemia |
| 09/01/2009 | US7582627 3-aminoquinazolin-2,4-dione antibacterial agents |
| 09/01/2009 | CA2393344C Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 08/27/2009 | WO2009104159A1 Oxazolidinone derivatives |
| 08/27/2009 | US20090215766 Tetracyclic inhibitors of janus kinases |
| 08/27/2009 | CA2713187A1 Oxazolidinone derivatives |
| 08/27/2009 | CA2713182A1 Azatricyclic antibiotic compounds |
| 08/26/2009 | EP1631569B1 Quinuclidine derivatives binding to mucarinic m3 receptors |
| 08/26/2009 | CN101516889A Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
| 08/26/2009 | CN101514196A Thiophene derivative and application thereof |
| 08/25/2009 | US7579471 Tropane derivatives useful in therapy |
| 08/25/2009 | US7579354 3-[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro- 1H-purin-8-yl)- bicyclo[2.2.2]oct-1-yl]-propionic acid or pharmaceutically acceptable salts; highly potent and selective diuretics; treatment of cardiac and circulatory disorders, degenerative disorders of central nervous system |
| 08/25/2009 | US7579348 selective antagonists of A2B adenosine receptors; for improving insulin sensitivity; asthma |
| 08/20/2009 | WO2009103032A1 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
| 08/20/2009 | WO2009102016A1 Compound having pyridoindole ring structure bonded with substituted pyridyl group, and organic electroluminescent device |
| 08/20/2009 | WO2009101917A1 Bicycloamine derivative |
| 08/20/2009 | CA2715658A1 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
| 08/20/2009 | CA2714591A1 Bicycloamine derivative |
| 08/20/2009 | CA2712946A1 Quinolizidinone m1 receptor positive allosteric modulators |
| 08/19/2009 | EP1641453B1 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 08/19/2009 | CN101511840A Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them |
| 08/19/2009 | CN101510590A Organic electroluminescent element and display |
| 08/19/2009 | CN101508697A Preparation method for vinorelbine |
| 08/19/2009 | CN100528882C Spirotetrathiocarbamates and spirooxothiocarbamates |
| 08/19/2009 | CN100528873C 3 position substituted mesoazalene compounds and high efficiency synthesis method |
| 08/18/2009 | US7576124 Anti-first-pass effect compounds |